Analysis of resistance to PLX4032 (2019-08-21)

Dataset ID Technology Samples
EGAD00001005278 Illumina HiSeq 2000 42

Dataset Description

We have collected material from a patient who had BrafV600E mutant melanoma that was
treated with PLX4032. We have germline DNA from the patient and DNA and RNA from
distinct lesions before and after treatment with PLX4032. We would like to exome sequence
these samples to gain a snap shot of the mechanisms of resistance that are operative.
This dataset contains all the data available for this study on 2019-08-21.

Who controls access to this dataset

For each dataset that requires controlled access, there is a corresponding Data Access Committee (DAC) who determine access permissions. Access to actual data files is not managed by the EGA. If you need to request access to this data set, please contact:

Wellcome Trust Sanger Institute
Contact person: Data Sharing
Email: datasharing [at] sanger [dot] ac [dot] uk
Access information:
More details: EGAC00001000205


You don't have access to the download section.